Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC).
Journal
Bone marrow transplantation
ISSN: 1476-5365
Titre abrégé: Bone Marrow Transplant
Pays: England
ID NLM: 8702459
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
10
10
2020
accepted:
13
04
2021
revised:
04
03
2021
pubmed:
16
5
2021
medline:
14
10
2021
entrez:
15
5
2021
Statut:
ppublish
Résumé
The public French Cord Blood Banks Network was established in 1999 with the objective of standardizing the practices governing umbilical cord blood (UCB) banking in France. The Network adopted a strategy to optimize its inventory and improve the quality of its banked units based on a quality improvement process using outcome data regularly provided by Eurocord. This study aimed to describe the results, over 10 years, of UCBT facilitated by a national network that used the same criteria of UCB collection and banking and to assess how modifications of banking criteria and unit selection might influence transplant outcomes. Nine hundred and ninety-nine units (593 single-unit and 203 double-unit grafts) were released by the Network to transplant 796 patients with malignant (83%) and non-malignant (17%) diseases. Median cell dose exceeded 3.5 × 10
Identifiants
pubmed: 33990703
doi: 10.1038/s41409-021-01313-x
pii: 10.1038/s41409-021-01313-x
pmc: PMC8120495
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2497-2509Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl J Med. 1989;321:1174–8.
pubmed: 2571931
doi: 10.1056/NEJM198910263211707
pmcid: 2571931
Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica. 2009;94:451–4.
pubmed: 19336748
pmcid: 2663606
doi: 10.3324/haematol.2009.005694
Gluckman E, Ruggeri A, Volt F, Cunha R, Boudjedir K, Rocha V. Milestones in umbilical cord blood transplantation. Br J Haematol. 2011;154:441–7.
pubmed: 21726206
doi: 10.1111/j.1365-2141.2011.08598.x
pmcid: 21726206
Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122:491–498.
Barker JN, Kurtzberg J, Ballen K, Boo M, Brunstein C, Cutler C, et al. Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies. Biol Blood Marrow Transpl. 2017;23:882–96.
doi: 10.1016/j.bbmt.2017.03.006
Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang M-J, Horowitz MM, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an hla-identical sibling. N. Engl J Med. 2000;342:1846–54.
pubmed: 10861319
doi: 10.1056/NEJM200006223422501
pmcid: 10861319
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl J Med. 2004;351:2276–85.
pubmed: 15564544
doi: 10.1056/NEJMoa041469
pmcid: 15564544
Weisdorf D, Eapen M, Ruggeri A, Zhang M-J, Zhong X, Brunstein C, et al. Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis. Biol Blood Marrow Transpl. 2014;20:816–22.
doi: 10.1016/j.bbmt.2014.02.020
Ruggeri A, Sanz G, Bittencourt H, Sanz J, Rambaldi A, Volt F, et al. Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT. Leukemia. 2014;28:779–86.
pubmed: 24005245
doi: 10.1038/leu.2013.259
pmcid: 24005245
Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang M-J, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N. Engl J Med. 2004;351:2265–75.
pubmed: 15564543
doi: 10.1056/NEJMoa041276
pmcid: 15564543
Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood. 2011;118:282–8.
pubmed: 21527516
pmcid: 3138683
doi: 10.1182/blood-2011-03-344853
Rocha V, Gluckman E, on behalf of the Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Br J Haematol. 2009;147:262–74.
pubmed: 19796275
doi: 10.1111/j.1365-2141.2009.07883.x
pmcid: 19796275
Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010;115:1843–9.
pubmed: 20029048
pmcid: 5003507
doi: 10.1182/blood-2009-07-231068
Eapen M, Klein JP, Sanz GF, Spellman S, Ruggeri A, Anasetti C, et al. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol. 2011;12:1214–21.
pubmed: 21982422
pmcid: 3245836
doi: 10.1016/S1470-2045(11)70260-1
Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood. 2014;123:133–40.
pubmed: 24141369
pmcid: 3879902
doi: 10.1182/blood-2013-05-506253
Eapen M, Wang T, Veys PA, Boelens JJ, St Martin A, Spellman S, et al. Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. Lancet Haematol. 2017;4:e325–33.
pubmed: 28623181
pmcid: 5699478
doi: 10.1016/S2352-3026(17)30104-7
Ruggeri A. Optimizing cord blood selection. Hematology. 2019;2019:522–31.
pubmed: 31808851
pmcid: 6913431
doi: 10.1182/hematology.2019000056
Dehn J, Spellman S, Hurley CK, Shaw BE, Barker JN, Burns LJ, et al. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood. 2019;134:924–34.
pubmed: 31292117
doi: 10.1182/blood.2019001212
pmcid: 31292117
Étude de législation comparée n° 187 - septembre 2008 - La conservation du sang placentaire. https://www.senat.fr/lc/lc187/lc187_mono.html . 2008.
International standards for cord blood collection, banking and release for administration, accreditation manual. http://www.factwebsite.org/uploadedFiles/Standards/NetCord%20FACT%206th%20Ed%20Manual%20Draft.09.01.15.pdf .
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825–8.
pubmed: 7581076
pmcid: 7581076
Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD, et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report. Biol Blood Marrow Transpl. 2006;12:491–505.
doi: 10.1016/j.bbmt.2006.03.004
Spyridonidis A, Labopin M, Savani BN, Niittyvuopio R, Blaise D, Craddock C, et al. Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients. Bone Marrow Transplant. 2020; https://doi.org/10.1038/s41409-020-0803-y .
Cox DR. Regression models and life-tables. J R Stat Soc Ser B Methodol. 1972;34:187–220.
Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706.
doi: 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O
Wagner JE, Broxmeyer HE, Byrd RL, Zehnbauer B, Schmeckpeper B, Shah N, et al. Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood. 1992;79:1874–81.
pubmed: 1348434
doi: 10.1182/blood.V79.7.1874.1874
pmcid: 1348434
Wagner JohnE, Steinbuch M, Kernan NancyA, Broxmayer HalE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet. 1995;346:214–9.
pubmed: 7616801
doi: 10.1016/S0140-6736(95)91268-1
pmcid: 7616801
Kurtzberg J, Laughlin M, Graham ML, Smith C, Olson JF, Halperin EC, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N. Engl J Med. 1996;335:157–66.
pubmed: 8657213
doi: 10.1056/NEJM199607183350303
pmcid: 8657213
Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl J Med. 1998;339:1565–77.
pubmed: 9828244
doi: 10.1056/NEJM199811263392201
pmcid: 9828244
Broxmeyer HE, Lee M-R, Hangoc G, Cooper S, Prasain N, Kim Y-J, et al. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood. 2011;117:4773–7.
pubmed: 21393480
pmcid: 3100689
doi: 10.1182/blood-2011-01-330514
Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92:10119–22.
pubmed: 7479737
pmcid: 40747
doi: 10.1073/pnas.92.22.10119
Rubinstein P, Taylor PE, Scaradavou A, Adamson JW, Migliaccio G, Emanuel D, et al. Unrelated placental blood for bone marrow reconstitution: organization of the placental blood program. Blood Cells. 1994;20:587–96 ; discussion 596-600.
pubmed: 7749124
pmcid: 7749124
Navarrete C, Contreras M. Cord blood banking: a historical perspective. Br J Haematol. 2009;147:236–45.
pubmed: 19796273
doi: 10.1111/j.1365-2141.2009.07827.x
pmcid: 19796273
Lazzari L, Corsini C, Curioni C, Lecchi L, Scalamogna M, Rebulla P, et al. The Milan Cord Blood Bank and the Italian Cord Blood Network. J Hematother. 1996;5:117–22.
pubmed: 8723786
doi: 10.1089/scd.1.1996.5.117
pmcid: 8723786
Navarrete C, Warwick R, Armitage S, Fehily D, Contreras M. The London Cord Blood Bank. Bone Marrow Transpl. 1998;22:S6–7.
Querol S, Gabarró M, Amat L, Gonzalez S, Gomez MD, de la Calle O, et al. The placental blood program of the Barcelona Cord Blood Bank. Bone Marrow Transpl. 1998;22:S3–5.
Dal Cortivo L, Marolleau JP, Gluckman E, Chavinié J, Brossard Y, Benbunan M. The Paris Cord Blood Bank. Bone Marrow Transpl. 1998;22:S11.
Wernet PW. The International Netcord Foundation. In: Broxmeyer He, editor. Cord blood: biology, immunology, banking and clinical transplantation. Bethesda, Md: Aabb Press; 2004. P. 429–35.
WMDA report. Total Number of Donors and Cord blood units. https://statistics.wmda.info/; https://wmda.info/cord-blood/basics-cord-blood/; 2020.
Mayani H, Wagner JE, Broxmeyer HE. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. Bone Marrow Transplant. 2020;55:48–61.
Magalon J, Gamerre M, Picard C, Chabannon C. Increase the quality of banked cord blood units without limiting HLA diversity: how cord blood banks could face this dilemma. Transfus. 2014;54:495–6.
doi: 10.1111/trf.12439
Stritesky G, Wadsworth K, Duffy M, Buck K, Dehn J. Evaluation of the impact of banking umbilical cord blood units with high cell dose for ethnically diverse patients. Transfus. 2018;58:345–51.
doi: 10.1111/trf.14410
Querol S, Gomez SG, Pagliuca A, Torrabadella M, Madrigal JA. Quality rather than quantity: the cord blood bank dilemma. Bone Marrow Transpl. 2010;45:970–8.
doi: 10.1038/bmt.2010.7
Feve F, Cambon-Thomsen A, Eliaou J-F, Gourraud P-A, Raffoux C, Florens J-P. Economic evaluation of the organization of a registry of haematopoietic stem cell donors. Rev Epidemiol Sante Publique. 2007;55:275–84.
pubmed: 17597327
doi: 10.1016/j.respe.2007.04.002
pmcid: 17597327
Ruggeri A, Paviglianiti A, Gluckman E, Rocha V. Impact of HLA in cord blood transplantation outcomes. HLA. 2016;87:413–21.
pubmed: 27060588
doi: 10.1111/tan.12792
pmcid: 27060588
Hough R, Danby R, Russell N, Marks D, Veys P, Shaw B, et al. Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols. Br J Haematol. 2016;172:360–70.
pubmed: 26577457
doi: 10.1111/bjh.13802
pmcid: 26577457
Gutman JA, Ross K, Smith C, Myint H, Lee C-K, Salit R, et al. Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation. Bone Marrow Transpl. 2016;51:1588–93.
doi: 10.1038/bmt.2016.186
Lazaryan A, Weisdorf DJ, DeFor T, Brunstein CG, MacMillan ML, Bejanyan N, et al. Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation with umbilical cord blood and matched sibling donors. Biol Blood Marrow Transpl. 2016;22:134–40.
doi: 10.1016/j.bbmt.2015.09.008
Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, et al. Cord-blood transplantation in patients with minimal residual disease. N. Engl J Med. 2016;375:944–53.
pubmed: 27602666
pmcid: 5513721
doi: 10.1056/NEJMoa1602074
Veys P, Danby R, Vora A, Slatter M, Wynn R, Lawson S, et al. UK experience of unrelated cord blood transplantation in paediatric patients. Br J Haematol. 2016;172:482–6.
pubmed: 26728432
doi: 10.1111/bjh.13914
pmcid: 26728432
Pupella S, Bianchi M, Ceccarelli A, Calteri D, Lombardini L, Giornetti A, et al. A cost analysis of public cord blood banks belonging to the Italian Cord Blood Network. Blood Transfus. Trasfus Sangue. 2018;16:313–20.
Sacchi N. Is it time to re-think a sustainable banking model for the Italian Cord Blood Network? Blood Transfus Trasfus Sangue. 2018;16:221–3.
Querol S, Rubinstein P, Marsh SGE, Goldman J, Madrigal JA. Cord blood banking: ‘providing cord blood banking for a nation. Br J Haematol. 2009;147:227–35.
pubmed: 19796272
doi: 10.1111/j.1365-2141.2009.07818.x
pmcid: 19796272
Magalon J, Maiers M, Kurtzberg J, Navarrete C, Rubinstein P, Brown C, et al. Banking or bankrupting: strategies for sustaining the economic future of public cord blood banks. PLoS ONE. 2015;10:e0143440.
pubmed: 26624279
pmcid: 4666404
doi: 10.1371/journal.pone.0143440
Rubinstein P. Cord blood banking for clinical transplantation. Bone Marrow Transpl. 2009;44:635–42.
doi: 10.1038/bmt.2009.281
Allan D, Kiernan J, Gragert L, Dibdin N, Bartlett D, Campbell T, et al. Reducing ethnic disparity in access to high-quality HLA-matched cord blood units for transplantation: analysis of the Canadian Blood Services’ Cord Blood Bank inventory. Transfus. 2019;59:2382–8.
doi: 10.1111/trf.15313
Mugishima H, Takahashi T, Nagamura T, Asano S, Saito H. Umbilical cord blood for unrelated bone marrow replacement; Asia bank and Japan cord blood bank network update. Int J Hematol. 2002;76:284–6.
pubmed: 12430938
doi: 10.1007/BF03165133
pmcid: 12430938
Kodera Y. The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry. Bone Marrow Transpl. 2008;42:S6.
doi: 10.1038/bmt.2008.103
Barker JN, Boughan K, Dahi PB, Devlin SM, Maloy MA, Naputo K, et al. Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis. Blood Adv. 2019;3:939–44.
pubmed: 30917950
pmcid: 6457223
doi: 10.1182/bloodadvances.2018028662
Bochtler W, Maiers M, Oudshoorn M et al. World Marrow Donor Association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant 2007;39: 737–41. https://doi.org/10.1038/sj.bmt.1705672 .